Lee Ainslie - Maverick Capital
Holding/activity history for SQZ Biotechnologies Co (SQZB)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2023 Q3 | 0 | 0 | Sell 100.00% | 0.01 | |
| 2023 Q2 | 1,050,286 | 0.01 | Reduce 0.14% | 0.00 | $0.27 |
| 2023 Q1 | 1,051,771 | 0.02 | Reduce 1.53% | 0.00 | $0.56 |
| 2022 Q4 | 1,068,155 | 0.02 | $0.74 | ||
| 2022 Q3 | 1,068,155 | 0.05 | $2.28 | ||
| 2022 Q2 | 1,068,155 | 0.09 | Add 1.08% | 0.00 | $3.18 |
| 2022 Q1 | 1,056,786 | 0.09 | $4.81 | ||
| 2021 Q4 | 1,056,786 | 0.11 | $8.93 | ||
| 2021 Q3 | 1,056,786 | 0.17 | Add 7.50% | 0.01 | $14.42 |
| 2021 Q2 | 983,096 | 0.13 | Add 2.42% | 0.00 | $14.45 |
| 2021 Q1 | 959,832 | 0.12 | Add 2.55% | 0.00 | $13.68 |
| 2020 Q4 | 935,971 | 0.43 | Buy | 0.43 | $28.98 |